Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 30;50(5):396-402.
doi: 10.1159/000531236. eCollection 2023 Oct.

Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors

Sabine Kayser  1   2 , Richard F Schlenk  2 , Marcus Steiner  1 , Harald Klüter  1 , Patrick Wuchter  1
Affiliations

Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors

Sabine Kayser et al. Transfus Med Hemother. .

Abstract

Introduction: Collection of peripheral blood stem cells (PBSCs) from healthy donors is a well-established process. We aimed to identify factors predictive of successful CD34+ PBSC collection and established a formula capable of predicting CD34+ cell yield.

Methods: We retrospectively evaluated 588 healthy adult donors (median age 29 years, range 18-69 years) at our institution from 2017 to 2022. The predicted minimal number of CD34+ cells was calculated as follows: (peripheral CD34+ cells/µL × adjusted collection efficiency of 30%) × total liters processed. This formula was further modified according to donor and recipient body weight (BW).

Results: Median total collection was 8.0 × 106 CD34+ cells/kg BW (range 1.0-47.1 × 106 cells/kg BW) with 522 donors (89%) collecting ≥5.0 × 106 cells/kg of recipient BW. A second leukapheresis (LP) was performed in 49 donors. Need for two LPs was more common in female donors (OR 6.68, 95% CI, 2.62-17.05; p < 0.001), donors with higher age (OR for 10 years difference 1.53, 95% CI, 1.15-2.03, p = 0.003), donors with WBC count <30 × 109/L after 5 days of granulocyte-colony stimulating factor (G-CSF) stimulation (OR, 4.33; 95% CI, 1.59-11.83; p = 0.004), and a donor/recipient weight ratio <1 (OR 6.21, 95% CI, 2.69-14.34; p < 0.001). Predictive factors for optimal LP (i.e., ≥5.0 × 106 CD34+ cells/kg of recipient BW) were peripheral blood (PB) CD34+ cell count >50/µL (OR 12.82, range 6.34-25.92, p < 0.001), male donor (OR 2.77, range 1.06-7.23, p = 0.04), and a donor/recipient weight ratio >1 (OR 3.12, range 1.57-6.24, p = 0.001). WBC, platelets, hemoglobin, and age had no significant predictive value. Predicted versus observed number of CD34+ cells/kg BW collected demonstrated a very strong linear correlation (r = 0.925, 95% CI, 0.912-0.936, p < 0.0001).

Conclusions: Of the routinely monitored indicators in PBSC donors, CD34+ cell count in PB is the most important factor in predicting G-CSF-induced PBSC yields. Higher age, female sex, WBC <30 × 109/L, and a donor/recipient weight ratio <1 are useful indicators for identifying suboptimal mobilizers. The modified formula has shown successful and consistent performance in the prediction of key outcome measures including the minimum CD34+ cell collection, determination of the required length of apheresis, and whether a second day of PBSC collection was necessary to achieve the respective collection goal.

Keywords: Allogeneic donors; Apheresis; Efficacy; Hematopoietic stem cell mobilization; Peripheral blood stem cells.

PubMed Disclaimer

Conflict of interest statement

All authors declare no competing conflict of interest.

Figures

Fig. 1.
Fig. 1.
Predicted versus actual collected CD34+ cells × 106/kg BW of the recipient in 588 LP sessions. Equation: log10(actual CD34+ cells collected) = 0.932 × [log10(predicted CD34+ cells to be collected)] − 0.237.
See this image and copyright information in PMC

References

    1. Appelbaum FR. Hematopoietic-cell transplantation at 50. N Engl J Med. 2007;357(15):1472–5. 10.1056/NEJMp078166. - DOI - PubMed
    1. Ballen KK, King RJ, Chitphakdithai P, Bolan CD Jr, Agura E, Hartzman RJ, et al. The national marrow donor program 20 years of unrelated donor hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2008;14(9 Suppl):2–7. 10.1016/j.bbmt.2008.05.017. - DOI - PubMed
    1. Karanes C, Nelson GO, Chitphakdithai P, Agura E, Ballen KK, Bolan CD, et al. Twenty years of unrelated donor hematopoietic cell transplantation for adult recipients facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant. 2008;14(9 Suppl):8–15. 10.1016/j.bbmt.2008.06.006. - DOI - PubMed
    1. Bolan CD, Hartzman RJ, Perry EH, Trainor L, Miller J, Miller R, et al. Donation activities and product integrity in unrelated donor allogeneic hematopoietic transplantation: experience of the National Marrow Donor Program. Biol Blood Marrow Transplant. 2008;14(9 Suppl):23–8. 10.1016/j.bbmt.2008.06.001. - DOI - PubMed
    1. Pierelli L, Perseghin P, Marchetti M, Accorsi P, Fanin R, Messina C, et al. Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Società Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process. Transfusion. 2012;52(4):893–905. 10.1111/j.1537-2995.2011.03385.x. - DOI - PubMed